The Hippo-YAP pathway: new connections between regulation of organ size and cancer
- PMID: 18955139
- PMCID: PMC3296452
- DOI: 10.1016/j.ceb.2008.10.001
The Hippo-YAP pathway: new connections between regulation of organ size and cancer
Abstract
The control of organ size is a basic biological question. In the past several years, the Hippo signaling pathway has been delineated and shown to be crucial in control of organ size in both Drosophila and mammals. Acting downstream of the Hippo pathway is the Yki/YAP/TAZ transcription co-activators. In mammalian cells, the Hippo pathway kinase cascade inhibits YAP and its paralog TAZ by phosphorylation and promotion of their cytoplasmic localization. The TEAD family transcription factors have recently been identified as evolutionarily conserved key mediators of YAP biological functions. yap is a candidate oncogene, and several other components of the Hippo pathway are tumor suppressors. Dysregulation of the Hippo pathway contributes to the loss of contact inhibition observed in cancer cells. Therefore, the Hippo-YAP pathway connects the regulation of organ size and tumorigenesis.
Figures


References
-
- Pan D. Hippo signaling in organ size control. Genes Dev. 2007;21:886–897. - PubMed
-
- Edgar BA. From cell structure to transcription: Hippo forges a new path. Cell. 2006;124:267–273. - PubMed
-
- Saucedo LJ, Edgar BA. Filling out the Hippo pathway. Nat Rev Mol Cell Biol. 2007;8:613–621. - PubMed
-
- Harvey K, Tapon N. The Salvador-Warts-Hippo pathway - an emerging tumour-suppressor network. Nat Rev Cancer. 2007;7:182–191. - PubMed
-
- Hariharan IK. Growth regulation: a beginning for the hippo pathway. Curr Biol. 2006;16:R1037–1039. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous